PMVP Q3 2022 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$84M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-0.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$285M

Total Liabilities

$24M

Stockholders' Equity

$261M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$19M	-$15M	-28.3%
Net Income	-$18M	-$15M	-21.4%